Table 1 General characteristics of the case and control groups
Characteristic | Case (n = 23) | Control (n = 92) | P-value |
|---|---|---|---|
Age (years) | 60.87 ± 10.90 | 59.32 ± 9.76 | 0.502 |
BMI (kg/m2) | 26.29 ± 3.26 | 25.36 ± 3.07 | 0.198 |
Gender (male) | 18 (78.26%) | 72 (78.26%) | 1.000 |
Smoking | 16 (69.56%) | 45 (48.91%) | 0.076 |
Hypertension | 13 (56.52%) | 56 (60.87%) | 0.703 |
Obesity | 5 (21.7%) | 14 (15.2%) | 0.451 |
Overweight | 19 (82.6%) | 65 (70.7%) | 0.248 |
Diabetes | 8 (34.78%) | 28 (30.43%) | 0.688 |
Hyperlipidemia | 4 (17.39%) | 24 (26.09%) | 0.385 |
Atrial fibrillation | 0 (0.00%) | 3 (3.26%) | 0.380 |
Myocardial infarction | 6 (26.09%) | 19 (20.65%) | 0.572 |
Stroke | 4 (17.39%) | 0 (0.00%) | 0.999 |
OSA | 14 (60.87%) | 21 (23.09%) | 0.002 |
Emergency operation | 8 (34.78%) | 10 (10.87%) | 0.007 |
Bivalirudin | 3 (13.04%) | 0 (0%) | 0.990 |
Postoperative tirofiban | 14 (60.87%) | 15 (16.30%) | 0.000 |
Heparin | 1 (4.35%) | 15 (16.30%) | 0.138 |
Statin | 18 (78.26%) | 91 (98.91%) | 0.004 |
Length of stent (mm) | 67.22 ± 31.64 | 38.60 ± 20.40 | <0.001 |